Status:
ENROLLING_BY_INVITATION
A Randomized Controlled Study of Conservative Treatment of Granulomatous Lobular Mastitis Combined With Psychiatric Disorders
Lead Sponsor:
Wuhan University
Conditions:
Breast Diseases
Mastitis Granulomatous
Eligibility:
FEMALE
18-60 years
Phase:
NA
Brief Summary
Granulomatous lobular mastitis (GLM) is a relatively rare chronic inflammatory disease of the breast in clinical practice. A small number of patients develop hyperprolactinemia during psychiatric drug...
Eligibility Criteria
Inclusion
- Patients aged 18 years or older with granulomatous lobular mastitis
- Patients with Psychiatric Disorders;
- Patients volunteered to participate in the study after informed consent.
Exclusion
- Patients were diagnosed with mastitis with other definite etiology confirmed by pathology
- Patients in acute exacerbation of mental illness
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 30 2027
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05395949
Start Date
January 1 2019
End Date
January 30 2027
Last Update
May 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China, 430071